Vildagliptin  + Metformin Tablets manufacturers & suppliers

Vildagliptin + Metformin Tablets

Form: Tablets

Strength: Vildagliptin 50 mg + Metformin 500 mg/850mg/1000mg

Reference Brands: Galvus Met (EU)

Category: Diabetes

Vildagliptin and Metformin combination tablets are approved in the European Union under brand names like Galvus Met, Eucreas, and Icandra. These are indicated for the treatment of type 2 diabetes mellitus in adults when diet, exercise, and monotherapy do not provide adequate glycemic control. The product is regulated by the European Medicines Agency (EMA) and follows strict pharmacovigilance and quality standards. As of now, no FDA approval exists for Vildagliptin in the USA, limiting its availability. Manufacturers must comply with EU GMP standards and labeling requirements. Pharmatradz.com facilitates sourcing EU-approved diabetic formulations globally.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Premixed Insulins (70/30, 50/50) Injectable

Strength: U-100

Form: Vials, pens

Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)

View Details
Insulin Lispro (Humalog) Injectable

Strength: U-100, U-200

Form: Vials/pens

Reference Brands: Humalog, Admelog, Fiasp(US); Humalog, Fiasp(EU)

View Details
Insulin Aspart (Novolog) Injectable

Strength: U-100, U-200

Form: Vials/pens

Reference Brands: Novolog, Fiasp(US &EU)

View Details
Insulin Glargine (Lantus) Injectable

Strength: U-100, U-300

Form: Vials/pens

Reference Brands: Lantus, Basaglar, Toujeo(US); Lantus, Toujeo(EU)

View Details

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.